Homocysteine levels and leukocyte telomere length

Atherosclerosis. 2008 Oct;200(2):271-7. doi: 10.1016/j.atherosclerosis.2007.12.035. Epub 2008 Feb 15.

Abstract

Objective: Elevated plasma homocysteine is a risk factor for vascular diseases, possibly due to homocysteine-mediated increase in oxidative stress and inflammation. As leukocyte telomere length (LTL) registers the cumulative oxidative stress and inflammation, we examined the relationship between homocysteine and LTL.

Methods: LTL was measured using the Southern blot method. The relationship between LTL and homocysteine levels was considered for confounding with the following covariates: age, sex, smoking, obesity, physical activity, menopause, hormone replacement therapy use and creatinine clearance.

Results: 1,319 healthy subjects were recruited from a population-based cohort. LTL was negatively correlated with plasma homocysteine levels, after adjustment for smoking, obesity, physical activity, menopause, hormone replacement therapy use and creatinine clearance. The difference in multiply-adjusted LTL between the highest and lowest tertile of homocysteine levels was 111 base pairs (p=0.004), corresponding to 6.0 years of telomeric aging. This relationship was further accentuated by decreased concentrations of serum folate and increased levels of C-reactive protein.

Conclusions: Increased homocysteine levels are associated with shortened LTL, further supporting the tenet that LTL is an index of cardiovascular risk.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Twin Study

MeSH terms

  • Adult
  • Cardiovascular Diseases / blood
  • Cohort Studies
  • Female
  • Homocysteine / blood*
  • Humans
  • Leukocytes / metabolism*
  • Male
  • Middle Aged
  • Models, Biological
  • Obesity / genetics
  • Oxidative Stress
  • Sex Factors
  • Smoking
  • Telomere / ultrastructure*

Substances

  • Homocysteine